| Product Name | Sacubitril-d4 |
| Product Code | DA-S004-h |
| Chemical name | Sacubitril-d4 |
| Synonyms | (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic Acid Ethyl Ester-d4; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic Acid Ethyl Ester-d4;[S-(R*,S*)]-[1,1'-Biphenyl]-4-pentanoic Acid,γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-Ethyl Ester-d4; |
| Impurity | NA |
| CAS Number | 1884269-07-1 |
| Alternate CAS # | NA |
| Molecular form | C24H25D4NO5 |
| Appearance | Off-White to Pale Yellow Gel |
| Melting Point | NA |
| Mol. Weight | 415.52 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes |
| Boiling Point | NA |
| Applications | Isotope labelled Sacubitril is an antihypertensive drug used in combination with Valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
